Merck hits a new high

about 1 year ago
No image

Since 19th April, Merck has been hitting the upper circuit and today, it hit a new high at Rs.2014, up 15%. The buzz on the counter for the past couple of days has been keeping the stock alive.

The buzz is on news that P&G will be buying a majority stake in Merck for Rs.1290 crore, as part of a global transaction to acquire Merck KGaA’s international consumer health business for $4.2 billion.

Merck’s consumer health business in India is one of the largest in supplying vitamins, minerals and supplements, with products such as Neurobion, Polybion, Femibion and Evion. 


Articles you may also like

Popular Comments

No comment posted for this article.